Introduction
pGHD, GHD
GROWTH FAILURE, SHORT STATURE, GHD
One of the most frequent reasons for patient referrals to pediatric endocrinologists is short stature (Pediatric GHD generally manifests as short stature and growth failure (Early diagnosis and treatment of pGHD is highly effective for increasing childhood height and attaining final adult height (Low treatment adherence is a significant cause of the suboptimal therapeutic response to daily rhGH therapy, and failure to adhere to the prescribed treatment schedule may interfere with the efficacy of pGHD therapy (Somatrogon is a long-acting rhGH containing the amino acid sequence of hGH and three copies of the carboxy-terminal peptide (CTP) from human chorionic gonadotropin (Considering that physicians’ perceptions and experiences of treatment are key drivers of the use of GH therapy in adults in clinical practice (The objectives of this study were to explore and describe: (1) physicians’ perspectives using once-weekly somatrogon to treat pediatric patients with GHD, and (2) physicians’ preference for, and satisfaction with, once-weekly somatrogon, compared with once-daily rhGH.